
- BioPharm International-10-15-2016
- Volume 2016 eBook
- Issue 2
Cell Line Quality Technologies
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Chinese hamster ovary (CHO) cells are a common and stable option for mammalian expression systems, but what are the other cell line options in upstream processing and how do they compare in quality and stability to CHO cells? And what are the best techniques for ensuring quality and stability in cell-line development? BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances and the analytical techniques companies can use to ensure quality and stability.
Articles in this issue
almost 10 years ago
Investigation Effectiveness Drives Human Performance Excellencealmost 10 years ago
Data Integrity Challenges in Manufacturingalmost 10 years ago
Evaluating Technology and Innovation in Biopharmaceutical Manufacturingalmost 10 years ago
Seeking Accelerated Biosimilar Characterizationalmost 10 years ago
Plant-Made Pharmaceuticals—Accelerating Drug Development Globallyalmost 10 years ago
Testing the BrothRelated to this article










